Scarica l'app Stockscreener
75.53
0.17%
-0.1395
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.67
Aprire:
$75.78
Volume 24 ore:
832.78K
Relative Volume:
0.31
Capitalizzazione di mercato:
$16.86B
Reddito:
$4.13B
Utile/perdita netta:
$543.90M
Rapporto P/E:
31.34
EPS:
2.41
Flusso di cassa netto:
$957.20M
1 W Prestazione:
-0.13%
1M Prestazione:
+0.24%
6M Prestazione:
+11.93%
1 anno Prestazione:
+23.19%
Intervallo 1D:
$75.50
$75.78
Intervallo di 1 settimana:
$75.44
$75.78
Portata 52W:
$51.90
$75.78
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.54 | 16.89B | 4.13B | 543.90M | 957.20M | 2.41 |
ISRG
Intuitive Surgical Inc
|
450.97 | 160.77B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
153.71 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
73.70 | 35.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.45 | 33.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
219.96 | 32.12B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Argus | Buy → Hold |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic stock consolidates as company recognized among America's most charitable firms - Traders Union
Vanguard (HOLX) amendment shows 0 shares after Jan 12, 2026 realignment - Stock Titan
Syquant Capital Sas Purchases New Stake in Hologic, Inc. $HOLX - marketbeat.com
Hologic (NASDAQ:HOLX) Sets New 52-Week HighTime to Buy? - MarketBeat
SG Americas Securities LLC Purchases 337,882 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic stock sees fresh institutional interest as Pensionfund Sabic buys 18,800 shares amid medical - AD HOC NEWS
HBK INVESTMENTS L P's Hologic Inc(HOLX) Holding History - gurufocus.com
HOLX or ALGN: Which Medical Technology Stock Should You Choose for Investment Right Now? - Bitget
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now? - TradingView
18,800 Shares in Hologic, Inc. $HOLX Bought by Pensionfund Sabic - MarketBeat
Loss Report: Does Hologic Inc have consistent dividend growth2026 Market Overview & Long-Term Investment Growth Plans - baoquankhu1.vn
Hologic, Inc. $HOLX Stake Boosted by Assenagon Asset Management S.A. - Defense World
Philippines improves in women’s health ranking but still lags among its peers in the regionBusinessWorld - BusinessWorld - BusinessWorld Online
Hologic upgraded at Evercore ISI on growth turnaround - MSN
Investors heavily search Hologic, Inc. (HOLX): Here is what you need to know - MSN
Investors Are Actively Looking Into Hologic, Inc. (HOLX): What You Should Be Aware Of - Bitget
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 MillionAnalysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More - Yahoo Finance
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening - Yahoo Finance
Hologic, Inc. $HOLX Shares Sold by JPMorgan Chase & Co. - MarketBeat
Should You Keep or Offload HOLX Shares as It Approaches the Conclusion of Its Public Phase? - Bitget
Is Hologic Stock Outperforming the Dow? - Yahoo Finance
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase? - TradingView
Mammography Devices Market Poised for Robust Growth at 8.25% - openPR.com
Mammography Devices Market Poised for Robust Growth at 8.25% CAGR Through 2034: DelveInsight | Hologic, GE Healthcare, and Siemens Healthineers - Barchart.com
Aug PreEarnings: How is Hologic Inc managing supply chain issuesGold Moves & Expert Curated Trade Setups - baoquankhu1.vn
1,5 Milliarden Frauen verpassen wichtige Vorsorgeuntersuchungen – trotz weltweit steigender Screening-Raten - Eagle-Tribune
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates - Investing News Network
Brevan Howard Capital Management LP Increases Position in Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Alliancebernstein L.P. - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Sectra acquiring Oxipit | RadNet's $300M in 2026 acquisitions | Hologic clears hurdle in $18B sale to PE | More - Radiology Business
Technical Reactions to HOLX Trends in Macro Strategies - Stock Traders Daily
Hologic, Inc. $HOLX Shares Purchased by Gotham Asset Management LLC - MarketBeat
Cinctive Capital Management LP Buys 23,119 Shares of Hologic, Inc. $HOLX - MarketBeat
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - MSN
Earnest Partners LLC Purchases 26,877 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Integral Health Asset Management LLC - MarketBeat
Why Hologic Just Hit Your Health And Money Feeds At Once - AD HOC NEWS
Korea Investment CORP Has $2.66 Million Stake in Hologic, Inc. $HOLX - MarketBeat
Mackenzie Financial Corp Sells 141,733 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Sexually Transmitted Disease Testing Market size to exceed - openPR.com
Natixis Advisors LLC Acquires 82,894 Shares of Hologic, Inc. $HOLX - MarketBeat
What Drives Hologic's GYN Surgical Strength in a Competitive Market? - The Globe and Mail
Dimensional Fund Advisors LP Has $155.75 Million Position in Hologic, Inc. $HOLX - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
What Factors Contribute to Hologic's GYN Surgical Success Amidst Market Competition? - Bitget
Hologic, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
BioZorb Lawsuit and Settlement Information: March 2026 - AboutLawsuits.com
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):